READ-ONLY DIGITIZATION RESULT
STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma.
J Clin Oncol · 2026-Mar-10 · PMID 41325560
Panel B提取完成待 EXE 对齐验证
overall survival
FIG 2. Kaplan-Meier curves of OS for the (A) ITT population and (B) IDH -mut grade 3 subset (investigator assessment by treatment). P values are from the log-rank test stratified by age (≤45 v > 45) and number of prior surgeries. For the ITT population P value was also stratified by IDH status (mutant v wild-type). CDKN2A/B , cyclin-dependent kinase inhibitor 2A/B ; IDH -mut, isocitrate dehydrogenase mutation; ITT, intention-to-treat; N, total number of patients; OS, overall survival.
算法:legacy-0.5.0引擎:enhanced-linux
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | complete | 待验证 | 2 | 2026-07-23T16:24:14+00:00 |